Human endokine alpha and methods of use

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/19 (2006.01) A61K 38/16 (2006.01) A61K 38/19 (2006.01) A61P 25/00 (2006.01) C07K 14/52 (2006.01) C07K 14/525 (2006.01) C12N 5/10 (2006.01) C12N 5/16 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2363779

The present invention concerns a novel member of the tumor necrosis factor (TNF) family of cytokines. In particular, isolated nucleic acid molecules are provided encoding the endokine alpha protein. Endokine alpha polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods concerning TNF family-related disorders.

L'invention concerne un nouveau membre de la famille de cytokines de facteur de nécrose tumorale (TNF). Cette invention concerne notamment des molécules d'acides nucléiques isolées codant la protéine alpha endokine, ainsi que des polypeptides endokine alpha, des vecteurs, des cellules hôtes et des méthodes de recombinaison permettant de les produire. Ladite invention concerne aussi des méthodes diagnostiques et thérapeutiques relatives aux troubles liés à la famille TNF.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human endokine alpha and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human endokine alpha and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human endokine alpha and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2019834

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.